Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors
TransThera Sciences (Nanjing), Inc.
TransThera Sciences (Nanjing), Inc.
Syros Pharmaceuticals
Gossamer Bio Inc.
Merck Sharp & Dohme LLC
AstraZeneca